Johnson & Johnson vaccine less effective against Delta variant: study

johnson johnson vaccine less effective against delta variant study

Sumary of Johnson & Johnson vaccine less effective against Delta variant: study:

  • A recent study from researchers at New York University found that the Johnson &
  • Johnson vaccine may be less effective in battling COVID-19 variants than vaccines made by Pfizer-BioNTech or Moderna.
  • A registered nurse fills a syringe with the Johnson &
  • Johnson COVID-19 vaccine at a pop up vaccination site in the Staten Island borough of New York.
  • (AP)According to the study, the mRNA-based vaccines Pfizer and Moderna were 94 to 95% effective in preventing COVID-19 whereas the “adenoviral vector-based” Johnson &
  • Johnson cited previous studies which showed that a single-shot of its COVID-19 vaccine was 85% vaccine “at protecting against severe disease and provided complete protection against hospitalization and death.

Want to know more click here go to source.

From -

Generic selectors
Exact matches only
Search in title
Search in content

Site Language

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.